A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening

NCT07395479 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Tumours

Interventions

GENETIC: V001-BCMA
GENETIC: V001-GPRC5D
GENETIC: V001-DLL3
GENETIC: V001-FcRH5

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences